Taylor, Cottrill, Erickson & Associates, Inc. Biogen Inc. Transaction History

Taylor, Cottrill, Erickson & Associates, Inc.

$340 Million
Q1 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$223.92 - $287.77 $166,596 - $214,100	-744 Closed	0 $0
Q3 2021 Oct 15, 2021	BUY	$282.99 - $369.05 $26,601 - $34,690	94 Added 14.46%	744 $211,000
Q2 2021 Jul 20, 2021	BUY	$259.0 - $414.71 $168,350 - $269,561	650 New	650 $225,000
Q2 2020 Jul 14, 2020	SELL	$258.66 - $342.55 $168,129 - $222,657	-650 Closed	0 $0
Q1 2020 Apr 15, 2020	BUY	$268.85 - $341.04 $174,752 - $221,676	650 New	650 $206,000

Q1 2019 Apr 29, 2019	SELL	$216.71 - $338.96 $191,354 - $299,301	-883 Closed	0 $0
Q4 2018 Jan 29, 2019	SELL	$278.5 - $352.75 $1,392 - $1,763	-5 Reduced 0.56%	883 $266,000
Q3 2018 Oct 24, 2018	SELL	$293.51 - $383.83 $17,610 - $23,029	-60 Reduced 6.33%	888 $314,000
Q2 2018 Jul 30, 2018	BUY	$257.52 - $306.91 $4,120 - $4,910	16 Added 1.72%	948 $275,000
Q1 2018 Apr 23, 2018	SELL	$260.13 - $367.91 $24,712 - $34,951	-95 Reduced 9.25%	932 $255,000
Q4 2017 Jan 24, 2018	BUY	$307.64 - $344.58 $3,076 - $3,445	10 Added 0.98%	1,027 $327,000
Q3 2017 Oct 19, 2017	BUY	$281.15 - $329.69 $285,929 - $335,294	1,017	1,017 $318,000

Others Institutions Holding BIIB

# of Institutions

1,047

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$3.74 Billion
0.07% of portfolio
Primecap Management CO Pasadena, CA

16.2M
Shares

$3.66 Billion
2.65% of portfolio
Black Rock Inc. New York, NY

14.1M
Shares

$3.19 Billion
0.07% of portfolio
State Street Corp Boston, MA

6.75M
Shares

$1.52 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.17M
Shares

$1.17 Billion
0.68% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor, Cottrill, Erickson & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor, Cottrill, Erickson & Associates, Inc. with notifications on news.

Account